Skip to main content
. Author manuscript; available in PMC: 2015 Oct 19.
Published in final edited form as: Vaccine. 2012 Nov 19;31(34):3396–3402. doi: 10.1016/j.vaccine.2012.11.027

Fig. 3.

Fig. 3

Rotavirus-specific IgG (A) and neutralizing activity (B) in sera of vaccinated mice. Mice (n = 6 per group) were immunized with MN coated with 5 µg, 0.5 µg, or 0 µg (mock) of IRV or by IM injection with 5 µg or 0.5 µg of IRV, or 5 µg of IRV reconstituted from coated MN. Serum samples collected at days 0, 10 and 28 after vaccination were analyzed for IgG and sera collected on day 28 were examined for neutralizing activity as described in the text. The character “*” indicates IRV reconstituted from coated MN. Error bars show standard deviation.